In licensing

In Licensing provides multilateral opportunities to global manufacturers and research companies to explore the untapped and versatile markets with a definite cost advantage. Often many innovative products are not uniformly available across the globe due to location and logistics constrains. Novogene facilitates commercial In Licensing services to strategically partner with the R&D facilities and Multinationals to achieve an early presence in the Asian markets. With our strong market presence and acquaintance with the regulatory practices & guidelines, we would ensure a fine collaborative framework to align strategically with Pharmaceutical companies through In Licensing services. The scope of In Licensing could be further back tracked to the clinical and product research phases as many a times Pharmaceutical companies are perplexed with a unilateral global strategy for clinical research and positioning of their innovative products. Novogene can help pool resources and design a joint strategy that would maximize market presence as well as profitability, leading to great deal of continuous innovation.

Invariably, In Licensing is one of the underutilized services due to the lack of competence and comprehensive approach towards research processes in some of the target markets like India. When it calls for the need of an exceptional player with dynamic approach, resources and expertise…Novogene stays ahead with its outstanding reputation, market presence, infrastructure management systems, quality practices and technical know – how. We have been assisting some of the Pharmaceutical majors in clinical research and In Licensing process to expedite their potential in some of the fastest growing markets. During the process of In Licensing, we adhere to a model code of obligation, ensuring the interests of manufactures and innovators are secured.